Variability in the cytokeratin staining intensity, which is reported to occur during the EMT, was observed in CTCs, while PSMA expression remained consistent, supporting the use of this marker to discriminate between CTCs and blood cells in patients with advanced prostate cancer. Here, FOLH1 is linked to Familial prostate cancer.